Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia

BACKGROUND: Despite their huge epidemiological impact, primary headaches, trigeminal neuralgia and other chronic pain conditions still receive suboptimal medical approach, even in developed countries. The limited efficacy of current pain-killers and prophylactic treatments stands among the main reas...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandrini, Giorgio, De Icco, Roberto, Tassorelli, Cristina, Smania, Nicola, Tamburin, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360746/
https://www.ncbi.nlm.nih.gov/pubmed/28324318
http://dx.doi.org/10.1186/s10194-017-0744-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360746/
https://www.ncbi.nlm.nih.gov/pubmed/28324318
http://dx.doi.org/10.1186/s10194-017-0744-z

Ejemplares similares